AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.1900
-0.0105 (-5.24%)
At close: Jul 24, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $3.05 million as of July 24, 2026. Its market cap has decreased by -82.73% in one year.
Market Cap
3.05M
Enterprise Value
3.04M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
ChartMarket Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 3.05M, a decrease of -85.04%. That is a compound annual growth rate of -35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.05M | -76.64% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 3.92M |
| Biomind Labs | 3.88M |
| Institute of Biomedical Research | 3.30M |
| Eastgate Biotech | 3.17M |
| Vaccinex | 3.16M |
| Enzolytics | 2.90M |
| Pacific Software | 2.87M |
| Bioxytran | 2.74M |